D
Revolution Medicines, Inc. RVMD
$39.12 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -194.57M -156.29M -133.23M -116.00M -161.54M
Total Depreciation and Amortization 3.09M 2.58M 2.60M 2.46M 2.56M
Total Amortization of Deferred Charges 300.00K 300.00K 200.00K 300.00K 300.00K
Total Other Non-Cash Items 10.87M 12.65M 7.01M -107.00K 16.96M
Change in Net Operating Assets 42.02M 10.34M -4.74M -47.21M 21.16M
Cash from Operations -138.29M -130.42M -128.17M -160.56M -120.56M
Capital Expenditure -1.22M -3.52M -2.40M -3.17M -2.32M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -391.68M -17.95M 110.34M -244.80M -378.09M
Cash from Investing -392.90M -21.47M 107.94M -247.97M -380.40M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 778.10M 77.29M 7.50M 810.00K 2.55M
Repurchase of Common Stock -- -- -- -- -4.03M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 95.71M -- -- -- 840.83M
Cash from Financing 873.81M 77.29M 7.50M 810.00K 839.35M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 342.61M -74.59M -12.72M -407.72M 338.39M
Weiss Ratings